These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2166455

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
    Lipworth BJ, Struthers AD, McDevitt DG.
    Am Rev Respir Dis; 1989 Sep; 140(3):586-92. PubMed ID: 2782734
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ.
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM, Phillips C, Wooler PA.
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [Abstract] [Full Text] [Related]

  • 7. Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.
    Lipworth BJ, Clark RA, Dhillon DP, Brown RA, McDevitt DG.
    Br J Clin Pharmacol; 1988 Nov; 26(5):527-33. PubMed ID: 2849969
    [Abstract] [Full Text] [Related]

  • 8. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.
    Kerstjens HA, Brand PL, Hughes MD, Robinson NJ, Postma DS, Sluiter HJ, Bleecker ER, Dekhuijzen PN, de Jong PM, Mengelers HJ.
    N Engl J Med; 1992 Nov 12; 327(20):1413-9. PubMed ID: 1357553
    [Abstract] [Full Text] [Related]

  • 9. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
    de Jong JW, Koëter GH, van der Mark TW, Postma DS.
    Thorax; 1996 Jul 12; 51(7):684-8. PubMed ID: 8882073
    [Abstract] [Full Text] [Related]

  • 10. Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline.
    Kaae R, Agertoft L, Pedersen S, Nordvall SL, Pedroletti C, Bengtsson T, Johannes-Hellberg I, Rosenborg J.
    Br J Clin Pharmacol; 2004 Oct 12; 58(4):411-8. PubMed ID: 15373934
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the bronchodilator effects of the same amounts of terbutaline aerosol given as a single or in divided doses.
    Dulfano MJ, Glass P, McPhillips JJ.
    Ann Allergy; 1977 Oct 12; 39(4):266-71. PubMed ID: 333997
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma.
    O'Connor BJ, Aikman SL, Barnes PJ.
    N Engl J Med; 1992 Oct 22; 327(17):1204-8. PubMed ID: 1357551
    [Abstract] [Full Text] [Related]

  • 14. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study.
    Ekström T, Ringdal N, Tukiainen P, Runnerström E, Soliman S.
    Ann Allergy Asthma Immunol; 1998 Sep 22; 81(3):225-30. PubMed ID: 9759798
    [Abstract] [Full Text] [Related]

  • 15. The effect of increasing doses of beta-agonists on airflow in patients with chronic airflow limitation.
    Jaeschke R, Guyatt GH, Cook D, Morris J, Willan A, McIlroy W, Harper S, Ramsdale H, Haddon R, Fitzgerald MJ.
    Respir Med; 1993 Aug 22; 87(6):433-8. PubMed ID: 8105519
    [Abstract] [Full Text] [Related]

  • 16. The influence of the AA 16 beta 2-adrenoceptor polymorphism on systemic and airway responses in asthma.
    van Veen A, Weller FR, Wierenga EA, Jansen HM, Jonkers RE.
    Pulm Pharmacol Ther; 2008 Aug 22; 21(1):73-8. PubMed ID: 17292646
    [Abstract] [Full Text] [Related]

  • 17. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.
    Jaeschke R, Guyatt GH, Willan A, Cook D, Harper S, Morris J, Ramsdale H, Haddon R, Newhouse M.
    Thorax; 1994 May 22; 49(5):479-84. PubMed ID: 8016770
    [Abstract] [Full Text] [Related]

  • 18. The bronchodilator test with increasing doses of terbutaline in chronic obstructive pulmonary disease patients.
    Rodríguez-Carballeira M, Heredia JL, Rué M, Quintana S, Gómez L.
    Pulm Pharmacol Ther; 2001 May 22; 14(1):61-5. PubMed ID: 11162421
    [Abstract] [Full Text] [Related]

  • 19. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis.
    Ullman A, Hedner J, Svedmyr N.
    Am Rev Respir Dis; 1990 Sep 22; 142(3):571-5. PubMed ID: 1975162
    [Abstract] [Full Text] [Related]

  • 20. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.
    Wong CS, Wahedna I, Pavord ID, Tattersfield AE.
    Am J Respir Crit Care Med; 1994 Nov 22; 150(5 Pt 1):1268-73. PubMed ID: 7952551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.